“…Gaze analysis has previously been conducted for various brain diseases, including Alzheimer’s disease, 11 ) Parkinson’s disease, 12 ) spinocerebellar degeneration, 13 ) posterior cortical atrophy, 14 , 15 ) and brain tumors. 16 ) These studies primarily considered the control function of the human gaze, such as gaze movements [including gaze fixation and saccade responses (movements between two fixations)], bottom–up function (a response wherein the gaze is drawn to a prominent object), and top–down function (a response wherein the gaze is actively searching for an object). 13 , 15 , 17 , 18 , 19 ) Prolonged gazing time and reduced saccade amplitude have been reported in patients with Alzheimer’s disease, 11 ) reduced saccade frequency and narrow gazing area in those with Parkinson’s disease, 12 ) reduced saccade amplitude and prolonged target gazing time in those with posterior cortical atrophy (sticky fixation, i.e., the inability to disengage from gazing at a target), 14 ) and eye movements such as gaze and gazing point movements 16 ) in those with brain tumors.…”